Global Health Innovative Technology Fund (GHIT): Product Development Platform - R&D partnerships with Japanese organizations – Intent to Apply

GHIT facilitates and funds partnerships between Japanese and non-Japanese organizations, for the discovery and development of new drugs, vaccines, and diagnostics for infectious diseases prevalent in developing countries. Disease scope includes: Malaria, TB, and NTDs. R&D focus may include: lead optimization / preclinical development / clinical development / activities to support licensure and WHO prequalification. No specified funding limit and project duration not specified.

https://ghitfund.org/afag/grant/en